Long-Term Weight Loss With Wegovy

At Hermann Aesthetics & Wellness, we’re thrilled to offer the latest FDA-approved prescription medication for obesity or excess weight. This daily injection has been met with remarkable praise following its FDA approval, dubbed a “game changer” by the New York Times.

What is Wegovy?

Wegovy is an injectable medication consisting of semaglutide. It’s approved for adults with obesity or who are overweight and have weight-related medical issues that prevent weight loss (such as high cholesterol, type 2 diabetes, and high blood pressure).  When it’s paired with a reduced-calorie diet and exercise regimen, Wegovy has proven to be effective as a long-term weight-loss medication. In a 68-week medical study, adults lost an average of 35 pounds, or approximately 15% of their body weight, while taking Wegovy. The study participants who took a placebo lost an average of 6 pounds or approximately 2.5% of their body weight. 

How Does Wegovy Work?

Wegovy works by imitating the hormone that affects the parts of the brain that regulate appetite and food intake. This can help people eat less food throughout the day, ultimately leading to weight loss.  Semaglutide has previously been approved by the FDA in the form of oral medication and lower-dose injections. As a higher-dose injection, Wegovy more effectively crosses the blood-brain barrier to promote weight loss. 

How Do I Take Wegovy?

Wegovy comes in five dose strengths. You’ll start with a 0.25 mg dose, then increase the dose every month until you arrive at the full 2.4 mg dose. However, make sure to follow the dosing plan that your healthcare provider recommends. As a long-term weight loss medication, Wegovy can be taken as long as it continues to benefit your weight management. Of course, patients will likely also be advised to stop taking Wegovy if it causes unwanted side effects. 

Does Wegovy Have Risks or Side Effects?

Wegovy has proven to be safe for patients with obesity, or those who are overweight with an underlying condition that inhibits weight loss. However, like virtually any prescription medication, it can produce side effects like diarrhea, constipation, and vomiting.  Additionally, Wegovy isn’t recommended for patients with a family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. This is because the risk of thyroid tumors was identified in animal studies (not human studies).  Wegovy is a new, exciting treatment option for obese and overweight patients looking to lose weight – and keep it off! To learn more, schedule an appointment with Dr. Hermann today.